[LRMR] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 5.71%
YoY- 14.24%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,274 -8,628 -15,067 -12,585 -14,675 -19,884 -14,689 -5.77%
Tax -50 -4,286 0 0 0 0 0 -
NP -10,274 -8,628 -15,067 -12,585 -14,675 -19,884 -14,689 -5.77%
Tax Rate - - - - - - - -
Total Cost 10,274 8,628 15,067 12,585 14,675 19,884 14,689 -5.77%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.64 -0.94 -4.11 -4.58 -5.37 -7.33 -6.47 -31.97%
EPS Diluted -0.64 -0.94 -4.11 -4.58 -5.37 -7.33 -6.47 -31.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.